戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 eveal that the SARS-CoV-2 virus becomes more infectious.
2  including by procedures that could generate infectious aerosols.
3 osis and antibiotics targeting this emerging infectious agent can eradicate the infection and prevent
4 egative staphylococci are a highly prominent infectious agent in peritonitis, and suggest caution aga
5  is the leading cause of death from a single infectious agent, requiring at least 6 months of multidr
6 ed forecasting systems treat ILI as a single infectious agent.
7 atory response results in the elimination of infectious agents by neutrophils and monocytes, followed
8 ss able to resist and/or eliminate secondary infectious agents due the effect of PRRSV on the thymus,
9 ic antibodies that can be protective against infectious agents exhibiting the same carbohydrate modif
10                                The idea that infectious agents in the brain have a role in the pathog
11 ppressing local or systemic immunity against infectious agents or cancer.
12           Stool specimens were tested for 37 infectious agents using TaqMan Array technology.
13 ophylactic vaccines that provoke immunity to infectious agents, as in allergy the patient is presensi
14  tract represents a portal of entry for many infectious agents; however, to date specific strategies
15 d for successful cytokinesis and survival of infectious amastigote forms inside mammalian macrophages
16 utic targets for immunotherapy of malignant, infectious and autoimmune diseases.
17  may benefit patients with COVID-19 or other infectious and autoinflammatory diseases by limiting tis
18 elopment of therapeutic strategies to target infectious and inflammatory diseases.
19  domestic medical examination (screening for infectious and noninfectious diseases/conditions) shortl
20 , particularly residents, who vomit are more infectious and tend to drive norovirus transmission in U
21                                   The highly infectious and zoonotic pathogen Francisella tularensis
22 ukemia virus (MLV), the S2 protein of equine infectious anemia virus (EIAV), and the Nef protein of h
23                                 However, the infectious associations between phages and bacteria in t
24 rasite immune evasion when ingested with the infectious blood meal and significantly reduce the preva
25 o, we have investigated its efficacy against infectious bronchitis using a broiler infection model.
26 cted with Klebsiella pneumoniae to determine infectious burden, immune cell abundance, and cytokine p
27 irus coinfection, we rescued two recombinant infectious bursal disease viruses (IBDVs) of strain PBG9
28 perative course with numerous immunological, infectious, cardiorespiratory, and psychological events,
29                                          Top infectious categories included non-specific symptoms, sk
30             Tuberculosis (TB) is the leading infectious cause of death globally, and drug-resistant T
31 an cytomegalovirus (HCMV) is the most common infectious cause of infant birth defects and an etiology
32 an cytomegalovirus (HCMV) is the most common infectious cause of infant birth defects, resulting in p
33                 Of the 275 child deaths with infectious causes, the most common contributory pathogen
34 that ZIKV spreads cell-to-cell in NPCs as an infectious center and that NPCs are more permissive to i
35 ned immunity and protection from a secondary infectious challenge in the skin.
36  cell memory and protective immunity against infectious challenge.
37 ngs suggest that the physiological stress of infectious challenges may drive AML progression in molec
38                                     Using an infectious clone of an enteric CoV, porcine epidemic dia
39        Compared with a clinical isolate, the infectious-clone-derived SARS-CoV-2 (icSARS-CoV-2) exhib
40 ng how a bacterial species comes to dominate infectious communities associated with respiratory infec
41 synbiotics significantly reduced the risk of infectious complications following abdominal surgery [re
42  bacterial pathogen commonly associated with infectious complications in susceptible individuals, suc
43                There were more patients with infectious complications in the n-3 PUFA group (8 compar
44 anned reoperation, myocardial infarction, or infectious complications.
45  cost of increased risks of life-threatening infectious complications.
46 juvant therapy in treating sight-threatening infectious corneal ulcers by promoting faster corneal ep
47 ocation and function of this mark within the infectious cycle is unknown.
48 fected Pompe cells and then assessed the VZV infectious cycle.
49 uss the basic biology of flaviviruses, their infectious cycles, the diseases they cause and underlyin
50             Each surface loop was evolved by infectious cycling in the presence of a helper adenoviru
51 ure/PCR-negative body fluids but for whom an infectious diagnosis was ultimately established, seven (
52 ols are needed for appropriate management of infectious diarrhea.
53 dback (PPRF) in November 2015 with mandatory infectious disease (ID) consultation for all meropenem a
54 review our experience of providing inpatient infectious disease (ID) consultations using real-time in
55     To determine the impact of these trends, infectious disease (ID) physicians were surveyed regardi
56 926-2019), National Institute of Allergy and Infectious Disease (R21 AI145356, R21 AI152318, and AI15
57 ntial to the broader response to coronavirus infectious disease 2019 (COVID-19), including epidemiolo
58 es the tissue susceptibility for coronavirus infectious disease 2019 infection.
59 tic benefit of monoclonal antibodies against infectious disease agents may be debatable, the function
60 My objective was to analyze recent trials in infectious disease and consider needs for future trials.
61 ct of anthropogenic nutrient supply rates on infectious disease and feedbacks to ecosystem carbon and
62 ms more human lives than any other bacterial infectious disease and represents a clear and present da
63  systems biology approaches for the study of infectious disease are quickly forming a new paradigm fo
64 otential to broaden our understanding of the infectious disease burden common to past populations fro
65 virus disease 2019 (COVID-19) is an emerging infectious disease caused by a novel coronavirus (SARS-C
66                             Diphtheria is an infectious disease caused by Corynebacterium diphtheriae
67                               COVID-19 is an infectious disease caused by the coronavirus SARS-CoV-2,
68 the use of high-flow oxygen, engagement with infectious disease consultants, and cardiac arrest.
69 arying prognostic for the growth rate of any infectious disease epidemic.
70                                           In infectious disease epidemiology, this coefficient is rel
71 learly a complex multifactorial disorder, an infectious disease etiology provides alternative therapy
72             Physicians and nurses who had no infectious disease expertise were recruited to provide c
73 opting this approach limits understanding of infectious disease impacts and hampers conservation effo
74 potential to become a point-of-care test for infectious disease in public health and clinical setting
75 are still associated with increased rates of infectious disease mortality such that an increase in PC
76 id corresponds with a 5% increase in risk of infectious disease mortality.
77 ogical thresholds and indices of health like infectious disease mortality.
78 s (MuV) is the causative agent of the highly infectious disease mumps.
79 about the care of these children, suggesting infectious disease outbreaks in these detainment centers
80 nical needs of patients affected by emerging infectious disease outbreaks.
81  to drive complex, nonlinear dynamics during infectious disease outbreaks.
82 atory response, immune cell trafficking, and infectious disease pathways.
83                                Applied to an infectious disease phylodynamic dataset of sequences fro
84 luding ophthalmologists, pulmonologists, and infectious disease physicians) generated preliminary con
85  year, billions of US$ are spent globally on infectious disease research and development.
86 neral increase in year-on-year investment in infectious disease research between 2000 and 2006, with
87 ly been used in a vast array of analyses for infectious disease research of public health relevance.
88 dentified a separation of bat ecologists and infectious disease researchers with few cross-disciplina
89 on whether biodiversity reduces or increases infectious disease risk, a question that directly affect
90                                Malaria is an infectious disease that affects over 216 million people
91 ors could lay the foundation for alternative infectious disease therapy using available therapeutic a
92 inferences of bacterial strain diversity and infectious disease transmission studies largely assume a
93 alidating SNPs and other factors controlling infectious disease transmission.
94 th programs, particularly those that involve infectious disease transmission.
95   The noninferiority trial design and recent infectious disease trials of relevance are discussed in
96 s a first-line therapeutic used to treat the infectious disease tuberculosis (TB), which is caused by
97            Tuberculosis (TB) remains a major infectious disease worldwide.
98 ecialties (73.1% for psychiatry to 87.8% for infectious disease).
99 fields of tick biology, allergy, immunology, infectious disease, and dermatology discussed the curren
100 ory, growth-promoting macrophages in a human infectious disease, biopsies from patients with leprosy
101 ists targeting nucleic acid sensors to treat infectious disease, cancer, and autoimmune and inflammat
102 inating DENV IgG against antibodies of other infectious disease, including the closely related Zika v
103 consulted for diagnosis and treatment of the infectious disease, it is clear that successful manageme
104                                              Infectious disease-induced MMEs (ID MMEs) have not been
105 evant in the age global change-induced human infectious disease.
106 ility of host populations to sustain endemic infectious disease.
107 important for understanding biodiversity and infectious disease.
108 ailable shortly after the emergence of a new infectious disease.
109 signs have been used to monitor the onset of infectious disease.
110 he leading cause of birth defects related to infectious disease.
111 African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede
112                                     Emerging infectious diseases (EIDs) of plants continue to devasta
113  that is widely used to develop vaccines for infectious diseases and cancer.
114 e detection of various pathogens involved in infectious diseases and food contamination.
115         US National Institute of Allergy and Infectious Diseases and National Cancer Institute, Natio
116 e powerful tools to develop immune memory to infectious diseases and prevent excess mortality.
117  pulmonary disease, including specialists in infectious diseases and pulmonary diseases.
118 ed prevention and treatment services for the infectious diseases and substance use disorder care cont
119                                              Infectious diseases are a major cause of morbidity and m
120 for shrimp-related pathogens remain unclear, infectious diseases are difficult to prevent and control
121                                      Because infectious diseases are implicated in pollinator decline
122 ss mortality events associated with emerging infectious diseases are often associated with high numbe
123 for the development of rapid diagnostics for infectious diseases because they have high sensitivity,
124  impact the spatial transmission dynamics of infectious diseases by introducing pathogens into suscep
125 n the efficacy of antibiotics and quality of infectious diseases care in critical care settings.
126         Vaccines save millions of lives from infectious diseases caused by viruses and bacteria.
127 between 01/2016 and 07/2019, who received an infectious diseases consultation for an invasive bacteri
128 s with clinical potential in response to new infectious diseases for which no specific drugs or vacci
129             The consensus definitions of the Infectious Diseases Group of the European Organization f
130 erstanding of spatiotemporal transmission of infectious diseases has improved significantly in recent
131                                              Infectious diseases have the potential to exacerbate the
132                                     Fighting Infectious Diseases in Emerging Countries and Bill & Mel
133  paper reviews (1) programs most relevant to infectious diseases in the 2018 SUPPORT Act; (2) opportu
134               Increased mortality rates from infectious diseases is a growing public health concern.
135                            Susceptibility to infectious diseases is determined by a complex interacti
136                                              Infectious diseases like tuberculosis (TB) and HIV are e
137 sk of autoimmune, metabolic, neoplastic, and infectious diseases of the intestine and mitigate the pa
138             According to the present view on infectious diseases pathogen resistance is linked to hum
139   Metagenomic next-generation sequencing for infectious diseases promises an unbiased approach to det
140 pports the National Institute of Allergy and Infectious Diseases research agenda.
141 g struggle with new, re-emerging and endemic infectious diseases serves as a frequent reminder of the
142        The American Thoracic Society (ATS) / Infectious Diseases Society of America (IDSA) Community-
143                                          The Infectious Diseases Society of America (IDSA) convened a
144            We provide evidence to revise the Infectious Diseases Society of America (IDSA) diabetic f
145                                    Thus, the Infectious Diseases Society of America (IDSA) recognized
146           Following the establishment of the Infectious Diseases Society of America (IDSA), women pla
147 uld be a key to the metagenomic diagnosis of infectious diseases when a microbe is visualized but rem
148 ins among the most common complications from infectious diseases worldwide.
149  microorganisms, and host protection against infectious diseases(1,2).
150 hich do not require advanced technology (eg, infectious diseases, addictions), can eventually lead to
151 tact tracing is used to control outbreaks of infectious diseases, and has been used for coronavirus d
152 ing potential to not only be used to monitor infectious diseases, but also to inform control policies
153 postexposure prophylaxis and/or treatment of infectious diseases, including other outbreaks of corona
154      Tuberculosis (TB), one of the deadliest infectious diseases, is caused by Mycobacterium tubercul
155            National Institute of Allergy and Infectious Diseases, Johns Hopkins Health System, and U.
156             In exploring the epidemiology of infectious diseases, networks have been used to reconstr
157 nd healthcare can increase susceptibility to infectious diseases, particularly among children.
158             For many life-threatening global infectious diseases, such as human immunodeficiency viru
159 c tests are first-line assays for diagnosing infectious diseases, such as malaria.
160 rgence and transcontinental spread of fungal infectious diseases, such as pandrug-resistant Candida a
161                                          For infectious diseases, the steady rise of antibiotic resis
162 erwhelming success of vaccines in preventing infectious diseases, there remain numerous globally deva
163 iseases-notably autoimmune, inflammatory and infectious diseases-and identifying potential therapeuti
164 and treatment of cancers, cardiovascular and infectious diseases.
165 cterization of behavioral changes induced by infectious diseases.
166  makes this species especially vulnerable to infectious diseases.
167  inclusion, diversity, access, and equity in infectious diseases.
168 caffolds as a source of therapeutics against infectious diseases.
169 opment and National Institute of Allergy and Infectious Diseases.
170 ling could be used to increase resistance to infectious diseases.
171 ies to target microorganisms responsible for infectious diseases.
172 id and inexpensive diagnostics of cancer and infectious diseases.
173  the society by reducing the transmission of infectious diseases.
174 stics are essential to control the spread of infectious diseases.
175 present the future trend in the diagnosis of infectious diseases.
176 in expanding checkpoint inhibitor therapy in infectious diseases.
177  the diagnosis, monitoring, and treatment of infectious diseases.
178 issue, especially with outbreaks of emerging infectious diseases.
179 o phenotypic variation such as resistance to infectious diseases.
180 gislation that will maximize the response to infectious diseases.
181 es have become an important tool in treating infectious diseases.
182 rantly regulated in several inflammatory and infectious diseases.
183 preferred method for rapid diagnosis of many infectious diseases.
184  aid in reducing the incidence and spread of infectious diseases.
185 an important animal model for AIDS and other infectious diseases.
186  during homeostasis, tissue development, and infectious diseases.
187  latter was estimated using a model based on infectious dose and the sensitivity of nucleic acid test
188 0 (XL-147) showing potent inhibition against infectious EBOV Zaire (0.09 muM) and MARV (0.64 muM).
189                                              Infectious encephalitis occurred in younger children (me
190     Five of 6 cases (83%) had culture-proven infectious endophthalmitis (2 Candida glabrata, 2 coagul
191 oxviruses produce two antigenically distinct infectious enveloped virions termed intracellular mature
192 of isolated BA is unknown, with evidence for infectious, environmental, and genetic risk factors desc
193  recorded regarding severity, type (cardiac, infectious, etc), etiology (surgical/medical), and timin
194 om (ER) is distinguishing between cardiac vs infectious etiologies for their pulmonary findings.
195                                              Infectious etiologies of diarrhea were identified in a h
196 arious diseases, in particular with those of infectious etiology, as well as with cardiovascular dise
197 nuclei that are present within granulomas of infectious etiology.
198 nts under active treatment developed serious infectious events, and two (10%) developed diverticular
199 eral, transport multiple virions en bloc via infectious extracellular vesicles, 100~1000 nm in diamet
200 on of the mutated C1 into a PK-resistant and infectious form perpetuating the biochemical characteris
201 al strains, is dispensable for production of infectious HCMV virions in multiple HCMV strains and cel
202 roduced intracellular-derived particles were infectious in liver-humanized mice with high RNA copy nu
203                         They are also highly infectious in their homologous host species.
204 ber of sporozoites that additionally are not infectious, indicating that PIMMS43 is also essential fo
205 w infections due to the presence of a single infectious individual at an event.
206                        Furthermore, numerous infectious, inflammatory, metabolic and genetic diseases
207  of defined patient populations with chronic infectious, inflammatory, or metabolic diseases.
208                                  Assembly of infectious influenza A viruses (IAV) is a complex proces
209                               Decreasing the infectious inoculum, varying the time between priming an
210           Francisella tularensis is a highly infectious intracellular bacterium that causes tularemia
211 1-year cumulative rates of RD or RD surgery, infectious keratitis, and CME were 1.0%, 0.8%, and 4.1%,
212 d with diseases of infectious keratitis, non-infectious keratitis, corneal dystrophy or degeneration,
213  outpatients newly enrolled with diseases of infectious keratitis, non-infectious keratitis, corneal
214 sion of KSHV-RTA/ORF50 nor the production of infectious KSHV virions in PEL.
215 h titres determined by plaque reduction with infectious LASV.
216 onal data.Three patients, all diagnosed with infectious mitral endocarditis, were diagnosed by micros
217      Up to 5% of university students develop infectious mononucleosis (IM) annually, and 9-12% meet c
218 tic phase is also essential for EBV to cause infectious mononucleosis and cancers, including B lympho
219 lasma converts into gametocytes that produce infectious oocysts (sporozoites) that are expelled into
220                                        Other infectious or autoimmune disorders were excluded.
221 lysis by causes of death (cardiac, vascular, infectious, or other) and place of death (clinical or no
222 key mechanism determining the severity of an infectious outbreak and that direct frequency dependent
223 c target to limit susceptibility and improve infectious outcomes in neonatal sepsis.
224 ntestinal microbiome and its relationship to infectious outcomes in patients with acute myeloid leuke
225 lant is associated with an increased risk of infectious outcomes or death in the ensuing 11months.
226 h limit exposure to environmental allergens, infectious parasitic worms, and microbes.
227 e plasmid in chlamydial differentiation into infectious particles in small intestine.
228 to determine whether HLH is the result of an infectious pathogen alone or genetic predisposition trig
229 ing infection, explaining its survival as an infectious pathogen in mice.
230 l infection.IMPORTANCE Rotavirus is a highly infectious pathogen that causes severe diarrhea.
231 are notorious for being vectors transmitting infectious pathogens and source of allergens causing all
232 (+) T cells, help to eliminate extracellular infectious pathogens that have invaded our tissues.
233 ntary information, allowing visualization of infectious pathophysiology beyond morphologic imaging.
234 ated the role of cellular calcium in the AAV infectious pathway.
235                                   For longer infectious periods and higher host densities, key trade-
236 th high cycle threshold are unlikely to have infectious potential.
237 h Rocky Mountain Laboratories prions yielded infectious prion nanoparticles including oligomers and m
238 eurons, exceptionally pure intact high-titer infectious prions are not directly neurotoxic.
239  schwannomas, assess for inflammatory and/or infectious processes, and detect residual and/or recurre
240 arrier, plasmid-deficient Chlamydia produced infectious progenies in small intestine but was 530-fold
241 lasmid-deficient Chlamydia failed to produce infectious progenies in small intestine, although infect
242 e level, plasmid-positive Chlamydia produced infectious progenies throughout gastrointestinal tract.
243 tious progenies in small intestine, although infectious progenies were eventually detected in large i
244  of viral proteins and genome packaging into infectious progeny, and egress and dissemination to the
245 sential for viral trafficking and release of infectious progeny, in various HCMV strains and cell typ
246 PrP(Sc) The high-resolution structure of the infectious PrP(Sc) state remains unknown, and its analys
247                         We use a susceptible-infectious-recovered (SIR) model for two coupled populat
248 me is likely to be made misunderstanding for infectious recurrent pharyngitis, it is important to not
249 rs allowing early detection and treatment of infectious reservoirs, as well as the in vivo analysis o
250 osuppressed transplant recipient relative to infectious risk and allograft function are lacking.
251                                To assess the infectious risk of CPIs, we evaluated the incidence of i
252 ed, but the 106 PFU dose was well tolerated, infectious (RSV/DeltaNS2/Delta1313/I1314L replication de
253                                  Shedding of infectious SARS-CoV-2 was observed up to 70 days, and of
254 semble into multimers and propagate into the infectious scrapie form known as PrP(Sc) The high-resolu
255  patients (30%) in the placebo group (with 6 infectious serious adverse events developing among 4 pat
256 atients (24%) in the rituximab group (with 9 infectious serious adverse events occurring among 6 pati
257 ow that PS is not required for production of infectious SFV or Chikungunya virus.
258 nriched on gRNA-specific regions and promote infectious SFV production and gRNA packaging.
259                  The prevailing view is that infectious spread is negligible in HTLV-1 persistence be
260   We find that, contrary to previous belief, infectious spread persists during chronic infection, eve
261 o that described for Toxoplasma gondii, with infectious stages traveling in freshwater runoff and bei
262 raded and mu1 is cleaved and exposed to form infectious subvirion particles (ISVPs).
263  of symptoms (i.e., cases) and those with no infectious symptoms (i.e., controls).
264  the clinical management of fever and common infectious syndromes in nonneutropenic adult inpatients.
265 ive in preventing TB among close contacts of infectious TB patients.
266 stant strains are widely believed to be less infectious than drug-susceptible strains.
267 ies in small intestine but was 530-fold less infectious than plasmid-positive Chlamydia, suggesting t
268             Here we show that D614G was more infectious than the ancestral form on human lung cells,
269  survived were significantly less stable and infectious than the wild type.
270 help to protect against pandemics and future infectious threats.
271 elerate the loss of an enterovirus (CVB3/28) infectious titer, with little effect on nearly identical
272 ng spike(D614G) (G614 virus) produced higher infectious titres in nasal washes and the trachea, but n
273 rvous system autoimmune diseases by inducing infectious tolerance whereby conventional B cells acquir
274 litis optic spectrum disorder (NMOSD) in 3%, infectious type in 2%, sarcoidosis in 2%, seronegative N
275 oplasmosis-associated IRIS were included (14 infectious/unmasking and 8 paradoxical), with an overall
276 lls and retinal endothelial cells during non-infectious uveitis.
277 nificantly lower than CMV-specific clones in infectious villitis.
278       The capsid protein (CA) content of the infectious viral cores is not well defined because metho
279 ing but largely unexploited strategy against infectious viral disease; as viruses infect cells, they
280 al viral proteins, not incorporated into the infectious viral particle, specifically the viral cystei
281 ultrastructural similarity to those found in infectious virions before cell entry were observed upon
282                      Electron micrographs of infectious virions depict particle-associated CP-delta f
283                Ubiquitinated E is present on infectious virions of ZIKV when they are released from s
284                    Some poxviruses sequester infectious virions outside of the factories in inclusion
285                               The release of infectious virions requires the production of capsid pro
286 rmed that it fails to produce late genes and infectious virions.
287 which consists of proteolytically processed, infectious virus progenies within autophagosome-derived
288 d KSHV spontaneous lytic gene expression and infectious virus release.
289 ie, show less severe symptoms, and shed less infectious virus themselves, when infected by vaccinated
290 h doses of favipiravir significantly reduced infectious virus titers in the lungs and markedly improv
291 roteins in A549 cells consistent with higher infectious virus titers.
292 n silico-designed DIs as fully encapsidated, infectious virus-like particles termed defective interfe
293 t lead to major changes in the production of infectious virus.
294  expression of IAV proteins but also contain infectious virus.
295 ct on RNA expression, protein abundance, and infectious-virus production.
296 Pases that convey resistance to a variety of infectious viruses.
297  M6PR-positive large endosomes and (ii) most infectious VZV particles in conventional cell substrates
298 ARS-CoV-2-infected individuals can be highly infectious while asymptomatic or pre-symptomatic, and th
299 y multiplying incidence by the length of the infectious window period.
300 monstrate that direct delivery in mice of an infectious ZIKV cDNA clone allows the rescue of recombin

 
Page Top